These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18269587)

  • 1. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.
    Skliris GP; Hubé F; Gheorghiu I; Mutawe MM; Penner C; Watson PH; Murphy LC; Leygue E; Myal Y
    Histopathology; 2008 Feb; 52(3):355-69. PubMed ID: 18269587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients.
    Liu L; Liu Z; Qu S; Zheng Z; Liu Y; Xie X; Song F
    Diagn Pathol; 2013 May; 8():71. PubMed ID: 23635316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
    Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of small breast epithelial mucin mRNA in peripheral blood of breast cancer patients and its clinical significance].
    Yang HW; Cao J; Yang NW; Liu JL; Zhang CM; Chen JS; Hong JS; Jiang Y; Su JJ
    Ai Zheng; 2005 Jul; 24(7):842-5. PubMed ID: 16004812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.
    Liu ZZ; Xie XD; Qu SX; Zheng ZD; Wang YK
    Clin Exp Metastasis; 2010 Apr; 27(4):251-9. PubMed ID: 20364301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.
    O'Brien N; O'Donovan N; Foley D; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Tumour Biol; 2007; 28(6):312-7. PubMed ID: 18253069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer.
    Ayerbes MV; Díaz-Prado S; Ayude D; Campelo RG; Iglesias P; Haz M; Medina V; Gallegos I; Quindós M; Aparicio LA
    Adv Exp Med Biol; 2008; 617():331-9. PubMed ID: 18497056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.
    Miksicek RJ; Myal Y; Watson PH; Walker C; Murphy LC; Leygue E
    Cancer Res; 2002 May; 62(10):2736-40. PubMed ID: 12019145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.
    Cheng KK; Dickson A; Gujam FJ; McMillan DC; Edwards J
    Histopathology; 2017 Apr; 70(5):782-797. PubMed ID: 27891654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
    van der Vegt B; de Roos MA; Peterse JL; Patriarca C; Hilkens J; de Bock GH; Wesseling J
    Histopathology; 2007 Sep; 51(3):322-35. PubMed ID: 17645748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
    Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
    Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
    Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
    Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.